The FDA has granted 510(k) clearance to the LifeLens physiological monitor, authorizing the device to track a wide range of vitals beyond its original ECG capabilities. This expansion allows the wearable system to measure blood oxygen, respiration, heart rate variability, and skin temperature, alongside movement and gait analysis data.
John Snow Labs has secured the top position in the 2026 MarketsandMarkets 360Quadrants report for NLP in Healthcare and Life Sciences. Outperforming 190 evaluated startups and SMEs, the company was recognized for its production-proven medical language models and its dominance across 12 of 13 clinical and biomedical AI benchmarks.
"I thought there should be a way to extend the hook and enhance its grip," said a Thornton, Colorado-based inventor regarding the development of the Measure Z. This new design addresses the persistent issue of tape hooks slipping or shifting during use, aiming to streamline professional and home improvement tasks alike.
Milwaukee-based law firm Ademi LLP has launched an investigation into the pending acquisition of Distribution Solutions Group by LKCM Headwater, citing concerns that the $35.00-per-share cash offer may fail to provide fair value to public shareholders while disproportionately benefiting company insiders.
Constellation Technology Ventures has secured a strategic equity stake in Blue Energy, marking the venture arm’s first investment in a U.S. developer of small modular reactors. The move signals a major push to standardize nuclear construction by applying shipyard-style prefabrication to financeable, large-scale power projects.
OutKick surged in the final quarter of 2026, recording 156 million total multiplatform minutes—a 101% increase over the same period last year. According to Comscore, the sports media platform outperformed competitors including DraftKings and The Ringer, securing 10.6 million unique visitors during the month of June alone.
Facing a surge in mental health demands within the justice system, Armor Health has tapped board-certified psychologist Dr. Syretta James to lead its behavioral health division. Her appointment signals a strategic shift toward data-driven, trauma-informed care models aimed at stabilizing clinical standards in correctional facilities nationwide.
Scissors met ribbon in Beavercreek this week as Commonwealth Hotels officially reopened the Courtyard Dayton Beavercreek following a comprehensive property-wide renovation. The ceremony drew local business leaders and hotel stakeholders to showcase a total reimagining of guest rooms and public spaces aimed at the Dayton region’s travel market.
A Montana inventor is looking to shave critical seconds off weapon deployment times with a new patent-pending holster design. Developed to prioritize speed during emergency encounters, the Fast Draw Pistol Holster aims to replace traditional carry methods with a streamlined, lightweight mechanism intended to bolster user preparedness.
Stamford-based Spectrum Business has introduced TV Control Pro, a centralized management platform designed to eliminate the logistical headache of juggling multiple remotes in high-traffic commercial spaces. The tool allows operators of bars and restaurants to sync dozens of screens through a single app-based interface during live events.
Investors will receive a detailed look at Federal Signal Corporation’s financial health on July 30, 2026, as the Downers Grove-based manufacturer prepares to release its second-quarter results before the opening bell. The announcement precedes a live conference call hosted by the company’s top executive leadership team.
At the San Mateo County Event Center, Makera is unveiling its latest desktop CNC machine, the Z1, during the Open Sauce 2026 creator festival. The company is using the event to demonstrate a unified ecosystem that pairs hardware with AI-driven software to lower the barrier for digital fabrication.
A projected surge in the oligonucleotide synthesis market will see valuations climb from $14.64 billion in 2026 to $32.72 billion by 2031. This 17.4% annual growth rate reflects a fundamental shift in biotechnology, as pharmaceutical pipelines move away from traditional small molecules toward complex, custom-engineered genetic therapies.
As AI models push hardware to its breaking point, ScaleFlux CEO Hao Zhong and NVIDIA storage lead Jason Hardy will take the stage at the Future of Memory and Storage 2026 conference to present a new blueprint for integrating flash memory into the data pipeline for large-scale AI deployments.
With over two decades of franchise development expertise, Connie Wallis joins Omaha-based Franchise FastLane to spearhead consultant relations. Her appointment arrives as the firm scales its operations following the 2026 acquisition of Franchise Creator and a recent ranking on the Inc. Fastest-Growing Private Companies list.
The treatment landscape for Complement 3 Glomerulopathy (C3G) is undergoing a significant shift as pharmaceutical developers race to move beyond traditional immunosuppressants. With the global market valued at approximately $1 billion in 2025, four distinct investigational therapies are emerging to challenge recently approved standards of care.
A federal class action lawsuit filed in the Southern District of New York accuses Megan Holdings Limited of masking internal accounting failures and facilitating a pump-and-dump scheme. The litigation, which follows a 93.4% collapse in share value, names the company, its top executives, and its IPO underwriter as defendants.
With Via Transportation shares cratering 69% since their September 2025 public offering, investors are now targeting the company’s leadership in a securities class action. A New York court has set an August 10, 2026, deadline for shareholders to apply for lead plaintiff status in the litigation.
Investors who purchased Calix, Inc. securities between January 28 and April 21, 2026, have until July 27 to seek lead plaintiff status in a pending class action. The lawsuit contends the company misled shareholders by masking the depletion of a low-cost memory stockpile behind generic supply chain risk warnings.
Investors who purchased ADMA Biologics stock between August 9, 2024, and March 25, 2026, face an August 10, 2026, deadline to seek lead plaintiff status in a pending securities class action. The lawsuit alleges the company misled shareholders by certifying internal controls while concealing channel stuffing and undisclosed related party transactions.
Investors who purchased Helen of Troy Limited shares between April 24, 2024, and October 8, 2025, are being urged to join a pending class action lawsuit. The litigation follows a series of sharp stock declines triggered by the collapse of the company’s internal restructuring initiative, known as Project Pegasus.
Investors who purchased Lucid Group, Inc. stock between February 25 and April 13, 2026, are being alerted to a pending class action lawsuit following a series of disclosures that erased 15.8% of the company's market value, amounting to combined losses of $1.57 per share.
A class-action lawsuit filed against Black Rock Coffee Bar, Inc. alleges the company misled investors by framing store cannibalization as a hypothetical future risk in its IPO prospectus. While the company warned that sales transfers might occur, the complaint contends that the financial erosion was already actively damaging operations.
A pending securities class action against Hub Group, Inc. gives investors until August 28, 2026, to seek lead plaintiff status. The litigation follows a sharp 28.6% drop in share price triggered by disclosures of a $77 million understatement in transportation and warehousing costs previously attributed to corporate efficiency.
A 50.55% single-day stock plunge has triggered a securities class action against Grail, Inc., with the court setting an August 4, 2026, deadline for lead plaintiff applications. The lawsuit targets the company’s alleged failure to disclose negative internal data during the NHS-Galleri trial.
Investors who purchased Embecta Corp. stock between November 25, 2025, and May 4, 2026, face an August 17, 2026, deadline to seek lead plaintiff status in a securities class action. The litigation follows a 57.8% single-day stock collapse triggered by a major earnings miss and a sharp reduction in fiscal guidance.
Investors in Futu Holdings Limited face an August 25, 2026, deadline to seek lead plaintiff status in a securities class action. The lawsuit targets CEO Leaf Hua Li and CFO Arthur Yu Chen, alleging they knowingly certified misleading SEC filings regarding the company's unlicensed operations in mainland China.
Investors who purchased Zoetis Inc. stock between January 14, 2025, and May 6, 2026, are facing a July 27, 2026, deadline to seek lead plaintiff status in a securities class action. The lawsuit alleges that management misled shareholders regarding the competitive standing and safety profile of its core companion animal products.
Investors in GeneDx Holdings Corp. face an August 3, 2026, deadline to apply for lead plaintiff status in a securities class action. The lawsuit targets CEO Katherine Stueland and CFO Kevin Feeley, alleging they misled shareholders regarding the integration and performance of Fabric Genomics, contributing to a 49.2% stock price collapse.
Investors who purchased First Solar, Inc. securities between February 26, 2025, and February 24, 2026, have until August 24, 2026, to file for lead plaintiff status in a pending class action lawsuit. The litigation centers on claims that the company misled shareholders regarding tariff impacts and production stability.
